Blogs
Approaching the end of an era for animal testing
The existing drug development paradigm was established in 1938 under the Federal Food, Drug, and Cosmetics Act (FFDCA) and still...
Blogs
The existing drug development paradigm was established in 1938 under the Federal Food, Drug, and Cosmetics Act (FFDCA) and still...
Meet Us
Imagen proudly partners with the 11th Annual PREDiCT Tumor Models London, to deliver the latest insights into cutting edge preclinical...
Product Sheets
Test the efficacy of your ADC using clinically relevant patient-derived cell (PDC) models
Blogs
Despite the improvement in clinical outcomes derived by the introduction of innovative targeted therapies and immunotherapies, lung cancer remains a...
Blogs
Typical ex vivo chemosensitivity assays initially designed to expose patient-derived cancer cells to certain drugs seemed an obvious and compelling...
Blogs
Traditional oncology treatments were designed to rapidly kill fast proliferating cells in a one-size-fits-all. However, once the first draft of...
Product Sheets
A pan-solid tumor drug screening service to help you move your drug development pipeline with confidence to the clinic
Model Spotlight
Amplification or overexpression of HER2 occurs in approximately 15–30% of breast cancers and 10–30% of gastric/gastroesophageal cancers and serves as...
Model Spotlight
Amplification or overexpression of HER2 occurs in approximately 15–30% of breast cancers and 10–30% of gastric/gastroesophageal cancers and serves as...
Blogs
For more than 25 years, the NCI-60, a panel of 60 human cancer cell lines grown in vitro, has been...
Product Sheets
Discover the power of our Patient-derived cell (PDC) model and high content imaging platform. Lengthy and costly drug development programs...
Blogs
A large and well characterised biobank of patient-derived cell models can significantly accelerate drug development timelines and fast track decisions...
Blogs
So, you’ve used conventional methodologies to identify a target, designed a series of candidate drugs and validated a biomarker for...
Posters
Patient-derived cell (PDC) models bridge the gap between conventional cancer lines that do not faithfully replicate clinical responses and costly...
Posters
New treatment strategies are urgently needed for metastatic breast cancer, which remains an area of high unmet need with poor...
Blogs
So, you’ve used conventional methodologies to identify a target, designed a series of candidate drugs and validated a biomarker for...
